These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 5710809

  • 1. [Studies on the osteotropic properties of radioactive chromium (51Cr). II].
    Wojciechoswki JM.
    Pol Przegl Radiol Med Nukl; 1968; 32(6):787-96. PubMed ID: 5710809
    [No Abstract] [Full Text] [Related]

  • 2. In vivo soubilization of insoluble chromium compounds: hydrolysis of 51Cr-cromic-32P-phosphate.
    Anghileri LJ.
    Nucl Med (Stuttg); 1968 Aug 30; 7(2):184-94. PubMed ID: 4972152
    [No Abstract] [Full Text] [Related]

  • 3. Radioactive chromic phosphates: comparative study of the in vivo distribution and feasibility of preparation.
    Anghileri LJ.
    J Nucl Med; 1967 Aug 30; 8(8):617-21. PubMed ID: 6051432
    [No Abstract] [Full Text] [Related]

  • 4. 51Cr EDTA and 51Cr DTPA: renal diagnostic agents influence of the method of preparation on their biological behaviour.
    Anghileri LJ.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul 30; 3(3):238-44. PubMed ID: 4989615
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on the mechanism of binding of radioactive chromium (51Cr) with proteins. II. Binding of radioactive chromium (51Cr) by free aminoacids].
    Kapuściński A.
    Pol Przegl Radiol Med Nukl; 1967 Jul 30; 31(5):735-45. PubMed ID: 6079195
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Experimental investigations on penetration of radioactive chromium (Cr51) through the skin.
    Czernielewski A, Brykalski D, Depczyk D.
    Dermatologica; 1965 Jul 30; 131(5):384-96. PubMed ID: 5865350
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Change of the half-life of survival of in vivo 51Cr labeled erythrocytes of the rat following whole-body irradiation with a dosage of 600 R].
    Dienstbier Z, Kocandrle K, Prouza A, Pospísil J.
    Cas Lek Cesk; 1968 May 31; 107(22):649-52. PubMed ID: 5661695
    [No Abstract] [Full Text] [Related]

  • 15. Use of 51Cr in studies on cellular immunity to Mycobacterium tuberculosis, Brucella melitensis and poliovirus, type I.
    Vickrey HM, Elberg SS.
    J Immunol; 1971 Jan 31; 106(1):191-9. PubMed ID: 5543710
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 51 Cr-polyphosphates: their general behaviour in normal and tumor bearing animals.
    Anghileri LJ, Miller ES.
    J Nucl Biol Med; 1971 Jan 31; 15(2):42-9. PubMed ID: 5171993
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The relationship between changes in the skeletal system and the dose of Sr 90 -radiation incorporated].
    Shvedov VL, Tuzhilkova TN, Semenova VP.
    Med Radiol (Mosk); 1972 Jul 31; 17(7):46-51. PubMed ID: 4662856
    [No Abstract] [Full Text] [Related]

  • 20. [Method of labelling of spleen cells in vitro by radioactive chromium (51Cr)].
    Doroszewski J, Krasuska W, Korycka M.
    Med Dosw Mikrobiol; 1969 Jul 31; 21(1):109-15. PubMed ID: 5789980
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.